Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says – National
Canada’s Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage
Read More
World News At Your Fingertips
Canada's Drug Agency